Also trades as: 0QPY.L (LSE) · $vol 22M · 0QPY.IL (IOB) · $vol 22M · SONVY (OTC) · $vol 1M · SONVF (OTC) · $vol 0M

CHF 248.40 ($299.96)

-1.80 (-0.72%)

Weekly Expected Move ±3.2%

CHF 233 CHF 241 CHF 248 CHF 256 CHF 264

SIX · Healthcare · Medical - Devices · Tech Score Buy · Power 62 · CHF 14.8B mcap · 49M float · 0.294% daily turnover

Revenue

$3.6B -0.2% ▼

5Y CAGR: +6.7%

Gross Profit

$2.7B -1.0% ▼

5Y CAGR: +7.2%

Operating Income

$676M -6.1% ▼

5Y CAGR: +1.8%

Net Income

$431M -20.3% ▼

5Y CAGR: -5.8%

EPS (Diluted)

$7.22 -20.1% ▼

5Y CAGR: -4.7%

EBITDA

$842M -1.0% ▼

5Y CAGR: +0.6%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$3.4B	$3.7B	$3.6B	$3.9B	$3.6B
YoY Growth	+29.3%	+11.1%	-3.0%	+6.6%	-0.2%
Cost of Revenue	$943M	$1.1B	$1.0B	$1.1B	$948M
Gross Profit	$2.5B	$2.6B	$2.6B	$2.8B	$2.7B
Gross Margin	73.2%	69.3%	72.0%	72.0%	73.7%
R&D Expenses	$230M	$243M	$239M	$235M	$234M
SG&A Expenses	$1.4B	$1.6B	$1.7B	$1.9B	$1.7B
Operating Expenses	$1.6B	$1.8B	$1.9B	$2.1B	$2.0B
Operating Income	$785M	$762M	$670M	$692M	$676M
Operating Margin	23.3%	20.4%	18.5%	17.9%	18.7%
Interest Expense	$34M	$23M	$29M	$28M	$29M
Income Before Tax	$728M	$712M	$647M	$652M	$642M
Tax Expense	$64M	$57M	$38M	$105M	$96M
Net Income	$649M	$648M	$601M	$540M	$431M
Net Margin	19.3%	17.3%	16.6%	14.0%	11.9%
EPS (Diluted)	$10.35	$10.71	$10.05	$9.04	$7.22
EBITDA	$893M	$974M	$918M	$927M	$842M
Shares Outstanding	63M	60M	60M	60M	61M

Line Item	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2	FY2026 Q4
Revenue	$1.8B	$1.9B	$1.8B	$1.9B	$1.8B	$2.0B	$1.8B	$1.8B
Cost of Revenue	$590M	$558M	$526M	$508M	$515M	$566M	$539M	$408M
Gross Profit	$1.3B	$1.3B	$1.2B	$1.4B	$1.3B	$1.5B	$1.3B	$1.4B
Gross Margin	68.0%	70.5%	70.0%	72.9%	71.9%	72.1%	70.3%	77.2%
R&D Expenses	$119M	$124M	$116M	$143M	$114M	$121M	$114M	$102M
SG&A Expenses	$771M	$815M	$796M	$860M	$908M	$950M	$901M	$813M
Operating Expenses	$890M	$938M	$911M	$1.0B	$1.0B	$1.1B	$1.0B	$966M
Operating Income	$366M	$395M	$316M	$364M	$279M	$413M	$260M	$416M
Operating Margin	19.8%	20.9%	18.0%	19.4%	15.2%	20.3%	14.3%	23.2%
Interest Expense	$22M	$28M	$22M	$17M	$28M	$1M	$33M	$55M
Income Before Tax	$349M	$363M	$291M	$354M	$255M	$397M	$234M	$407M
Tax Expense	$54M	$3M	$44M	-$6M	$47M	$58M	$42M	$54M
Net Income	$292M	$356M	$245M	$356M	$209M	$332M	$188M	$242M
Net Margin	15.8%	18.8%	14.0%	19.0%	11.4%	16.3%	10.4%	13.5%
EPS (Diluted)	$4.78	$5.93	$4.09	$5.96	$3.49	$5.55	$3.16	$4.06
EBITDA	$488M	$512M	$434M	$393M	$417M	$510M	$377M	$465M
Shares Outstanding	61M	60M	60M	60M	60M	60M	60M	60M

SOON.SW SIX